secwatch.observer — SEC 8-K summary
======================================

Issuer:     BELLICUM PHARMACEUTICALS, INC (—)
CIK:        0001358403
Form:       8-K
Filed at:   2023-04-11T23:59:59+00:00
Accession:  0001628280-23-011198
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellicum receives dual Nasdaq deficiency notices for equity and bid price
-------------------------------------------------------------------------

- Stockholders' equity below Nasdaq Capital Market requirement of $2.5M per April 6 notice; 45 days to submit compliance plan.
- Bid price closed below $1.00 for 30 consecutive days as of April 10; 180 days to regain compliance.
- If bid price falls to $0.10 or less for 10 straight days, immediate delisting may occur.
- Company evaluating options but cannot assure compliance will be achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1358403/000162828023011198/0001628280-23-011198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1358403/000162828023011198/blcm-20230406.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-011198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer